Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chang An Kang capsule vs mesalazine for chronic ulcerative colitis
CTR20131847Phase 3Active
- Sponsor
- Huaxia Yisheng
- Start
- Jan 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Chang An Kang capsule in autoimmune colitis, sponsored by Huaxia Yisheng. Started Jan 2015; status: active.
02
Drugs
Chang An Kang capsule
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20131847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131847.